Zobrazeno 1 - 4
of 4
pro vyhledávání: '"François Diévart"'
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-14 (2023)
Abstract Due to their cardiovascular protective effect, glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) represent breakthrough therapies for type 2 diabetes mellitus (T2DM). In this review
Externí odkaz:
https://doaj.org/article/6420101921534b9f9d011a67767b1819
Autor:
Eva Gerdts, Isabella Sudano, Sofie Brouwers, Claudio Borghi, Rosa Maria Bruno, Claudio Ceconi, Véronique Cornelissen, François Diévart, Marc Ferrini, Thomas Kahan, Maja-Lisa Løchen, Angela H E M Maas, Felix Mahfoud, Anastasia S Mihailidou, Trine Moholdt, Gianfranco Parati, Giovanni de Simone
Publikováno v:
European Heart Journal
There is strong evidence that sex chromosomes and sex hormones influence blood pressure (BP) regulation, distribution of cardiovascular (CV) risk factors and co-morbidities differentially in females and males with essential arterial hypertension. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13fd9f85dca6c3de8520ede2bb2c8c8d
Autor:
Michel Galinier, François Diévart, Stéphane Sadrin, Mélanie Gaubert, J M Maixent, Thomas Bardin, Alain Cohen-Solal, Régis Guieu, Franck Paganelli, Jean-Pierre Fauvel
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, MDPI, 2020, 21 (11), pp.4066. ⟨10.3390/ijms21114066⟩
International Journal of Molecular Sciences, 2020, 21 (11), pp.4066. ⟨10.3390/ijms21114066⟩
International Journal of Molecular Sciences, MDPI, 2020, 21 (11), pp.4066. ⟨10.3390/ijms21114066⟩
International Journal of Molecular Sciences, 2020, 21 (11), pp.4066. ⟨10.3390/ijms21114066⟩
International audience; Since the publication of the Framingham Heart Study, which suggested that uric acid should no longer be associated with coronary heart disease after additional adjustment for cardiovascular disease risk factors, the number of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8d5589a0e1b93896c65dc182fa72a92
http://europepmc.org/articles/PMC7312288
http://europepmc.org/articles/PMC7312288
Autor:
Dimitrios Richter, Luigina Guasti, Friedrich Koehler, Alessandro Squizzato, Stefano Nistri, Ruxandra Christodorescu, Francois Dievart, Giovanni Gaudio, Riccardo Asteggiano, Marc Ferrini
Publikováno v:
ESC Heart Failure, Vol 8, Iss 5, Pp 3483-3494 (2021)
Abstract Cardiovascular (CV) engagement in coronavirus disease 2019 (COVID‐19) is a huge determinant of prognosis during the acute phase of the disease. However, little is known about the potential chronic implications of the late phase of COVID‐
Externí odkaz:
https://doaj.org/article/693055d8cd294b7f8005e6cfdcd27a5a